CALLAN JMB Business Summary

Callan JMB Inc. (CJMB) is a vertically integrated logistics and fulfillment provider specializing in cold chain management for the life sciences and emergency response sectors. The company generates revenue through a mix of long-term government service contracts, such as its $9.1 million agreement with the City of Chicago, and strategic profit-sharing partnerships, notably a 2026 agreement with Attune Biotech structured at 50-60% profit splits. CJMB operates across four primary segments: healthcare logistics (specializing in GLP-1 and vaccine distribution), emergency preparedness (supporting BARDA and the Strategic National Stockpile), food sampling, and contract development manufacturing. Positioned as a niche "last-mile" fulfillment partner for highly regulated materials, CJMB competes directly with specialized logistics firms such as Air T Inc., Forward Air Corporation, and Freightos Ltd., distinguishing itself through its proprietary Sentry 4.0 monitoring technology and rapid 24-hour emergency deployment capabilities. Leadership is spearheaded by Founder, CEO, and Chairman Wayne Williams, a cold chain logistics expert who previously directed logistics for Logistics Health Inc. and currently maintains a 51.43% majority ownership stake. The executive team includes Interim CFO Christopher Shields, who also serves as SVP of Emergency Preparedness, and COO Scott Bullard, who brings over three decades of experience in vaccine logistics and partnerships with major pharmaceutical firms like Merck. Technical operations are managed by CIO William McBride, a specialist in biological specimen repository management and quality assurance. The company’s board includes notable industry veterans such as Mark Meller, CEO of SWK Technologies, and Executive Vice President Eric L. Kash, who provides extensive expertise in public market capital structures following the company's February 2025 IPO.